Skyrizi 600 mg/10 ml

Skyrizi 600 mg/10 ml is a medicine authorised by Swissmedic under authorisation number 68947. The authorisation holder is AbbVie AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 September 2023 and the authorisation is limited until 13 September 2028. ATC code L04AC18 places the medicine in the group Immunosuppressants.

  • Dispensing category B
  • Authorisation number 68947
  • ATC L04AC18
  • Biotechnological medicines
Authorisation data
Authorisation number68947
NameSkyrizi 600 mg/10 ml
Full nameSkyrizi 600 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
Authorisation holderAbbVie AG
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeL04AC18
First authorisation14 September 2023
Authorisation validity13 September 2028
Strengths
No.NameDispensing categoryAuthorisation date
1Skyrizi 600 mg/10 ml, Konzentrat zur Herstellung einer InfusionslösungB14 September 2023

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Durchstechflasche(n)L04AC1807.15.0.B
22Durchstechflasche(n)L04AC1807.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Skyrizi 600 mg/10 ml authorised in Switzerland?

Yes. Skyrizi 600 mg/10 ml is authorised by Swissmedic under authorisation number 68947, data as of 01 September 2026. The authorisation is limited until 13 September 2028.

Which dispensing category does Skyrizi 600 mg/10 ml have?

Skyrizi 600 mg/10 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Skyrizi 600 mg/10 ml?

The authorisation holder is AbbVie AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com